Ironwood Pharma (IRWD) Misses Q2 EPS by 4c, Revenues Miss; Offers 2018 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. SPCX
3. MU
4. SPY
5. ACN
6. IBM
7. PRIM
8. PFE
9. TSLA
10. DPZ

Go back to Ironwood Pharma (IRWD) Misses Q2 EPS by 4c, Revenues Miss; Offers 2018 Guidance

Ironwood Pharmaceuticals (IRWD) PT Raised to $27 at Mizuho Securities

August 7, 2018 4:12 AM EDT

Mizuho Securities raised its price target on Ironwood Pharmaceuticals (NASDAQ: IRWD) to $27.00 (from $25.00) while maintaining a Buy rating.

... More